Last reviewed · How we verify

NCT03185416: EPIICC

Early Palliative Care Integration in Interventional Cancer Care

Withdrawn NA Last updated 9 April 2018
What this trial tests

NA trial testing Palliative Care Training in Palliative Care. Withdrawn.

Timeline
1 August 2018
Primary endpoint
1 August 2019
1 August 2019

Quick facts

Lead sponsorUniversity of Miami
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Start date1 August 2018
Primary completion1 August 2019
Estimated completion1 August 2019

Drugs / interventions tested

Conditions studied

Sponsor

University of Miami

Who can join

18 and older, any sex, with Palliative Care or Cancer Liver. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A mixed methods randomized control trial assessing the impact of early palliative care incorporation in liver cancer and metastatic colorectal cancer on caregiver well-being, patient physical and psychosocial outcomes, and health services utilization.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Palliative Care Training

Trials testing the same drug.

Other recruiting trials for Palliative Care

Currently open trials in the same condition.

Other University of Miami trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03185416.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing